# Atara Biotherapeutics, Inc. (ATRA) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $36M |
| 2024 | -$83M |
| 2023 | -$276M |
| 2022 | -$281M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$3M |
| 2025-09-30 | -$4M |
| 2025-06-30 | $3M |
| 2025-03-31 | $39M |
| 2024-09-30 | -$22M |
| 2024-06-30 | -$18M |
| 2024-03-31 | -$31M |
| 2023-09-30 | -$70M |
| 2023-06-30 | -$71M |
| 2023-03-31 | -$75M |
| 2022-09-30 | -$85M |
| 2022-06-30 | -$32M |
| 2022-03-31 | -$88M |

Source: [CompaniesByCap](https://companiesbycap.com/company/ATRA/operating-income)